CN1044118C - 7－异二氢氮杂茚基－喹诺酮衍生物及其制备方法 - Google Patents

7－异二氢氮杂茚基－喹诺酮衍生物及其制备方法 Download PDF

Info

Publication number
CN1044118C
CN1044118C CN93117746A CN93117746A CN1044118C CN 1044118 C CN1044118 C CN 1044118C CN 93117746 A CN93117746 A CN 93117746A CN 93117746 A CN93117746 A CN 93117746A CN 1044118 C CN1044118 C CN 1044118C
Authority
CN
China
Prior art keywords
oxo
azabicyclo
dihydro
title compound
cyclopropyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN93117746A
Other languages
English (en)
Chinese (zh)
Other versions
CN1087634A (zh
Inventor
T·菲利普斯
S·巴特尔
A·克雷斯
U·彼得森
T·申克
K·D·布伦姆
R·恩达曼
K·G·梅茨格
B·米尔克
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Publication of CN1087634A publication Critical patent/CN1087634A/zh
Application granted granted Critical
Publication of CN1044118C publication Critical patent/CN1044118C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/06—Peri-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Quinoline Compounds (AREA)
  • Medicinal Preparation (AREA)
CN93117746A 1992-09-15 1993-09-15 7－异二氢氮杂茚基－喹诺酮衍生物及其制备方法 Expired - Fee Related CN1044118C (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DEP4230804.6 1992-09-15
DE4230804A DE4230804A1 (de) 1992-09-15 1992-09-15 7-Isoindolinyl-chinolon- und -naphthyridon-Derivate

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CN97123048A Division CN1189494A (zh) 1992-09-15 1997-11-26 取代的异氮杂茚化合物

Publications (2)

Publication Number Publication Date
CN1087634A CN1087634A (zh) 1994-06-08
CN1044118C true CN1044118C (zh) 1999-07-14

Family

ID=6467987

Family Applications (1)

Application Number Title Priority Date Filing Date
CN93117746A Expired - Fee Related CN1044118C (zh) 1992-09-15 1993-09-15 7－异二氢氮杂茚基－喹诺酮衍生物及其制备方法

Country Status (27)

Country Link
US (3) US5556979A (enExample)
EP (1) EP0588166B1 (enExample)
JP (1) JP3199930B2 (enExample)
KR (1) KR100288522B1 (enExample)
CN (1) CN1044118C (enExample)
AT (1) ATE138920T1 (enExample)
AU (2) AU668743B2 (enExample)
CA (2) CA2105923C (enExample)
CZ (1) CZ288493B6 (enExample)
DE (2) DE4230804A1 (enExample)
DK (1) DK0588166T3 (enExample)
ES (1) ES2088618T3 (enExample)
FI (1) FI934004A7 (enExample)
GR (1) GR3020484T3 (enExample)
HU (1) HU222348B1 (enExample)
ID (1) ID23959A (enExample)
IL (1) IL106990A (enExample)
MX (1) MX9305256A (enExample)
MY (1) MY131373A (enExample)
NO (1) NO304944B1 (enExample)
NZ (2) NZ248631A (enExample)
PL (3) PL177140B1 (enExample)
RU (1) RU2111964C1 (enExample)
SK (1) SK282274B6 (enExample)
TW (1) TW316899B (enExample)
UA (1) UA35562C2 (enExample)
ZA (1) ZA936759B (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3268098B2 (ja) * 1992-12-25 2002-03-25 第一製薬株式会社 二環性環状アミン誘導体
DE4301246A1 (de) * 1993-01-19 1994-07-21 Bayer Ag Chinolon- und Naphthyridoncarbonsäurederivate
US5508424A (en) * 1993-03-26 1996-04-16 Ortho Pharmaceutical Corporation 4-arylisoindole analgesics
WO1994025464A1 (en) * 1993-04-24 1994-11-10 Korea Research Institute Of Chemical Technology Novel quinolone carboxylic acid derivatives and process for preparing the same
KR950018003A (ko) * 1993-12-09 1995-07-22 스미스클라인 비참 피엘씨 신규한 퀴놀론 유도체 및 그의 제조 방법
DE4418510A1 (de) * 1994-05-27 1995-11-30 Bayer Ag 1,9-überbrückte Thiazolol[3,4-a]chinolinderivate
DE4427530A1 (de) * 1994-08-04 1996-02-08 Bayer Ag Chinolon- und Naphthyridoncarbonsäure-Derivate
DE4435479A1 (de) 1994-10-04 1996-04-11 Bayer Ag Chinolon- und Naphthyridoncarbonsäure-Derivate
DE19500792A1 (de) * 1995-01-13 1996-07-18 Bayer Ag Chinolon- und Naphthyridoncarbonsäure-Derivate
DE19506535A1 (de) * 1995-02-09 1996-08-14 Bayer Ag 1,6-Naphthyridoncarbonsäurederivate
ES2158963T3 (es) * 1995-02-09 2001-09-16 Bayer Ag Derivados de acidos 1,6-naftiridoncarboxilicos.
DE19722812C2 (de) * 1997-05-30 2003-02-13 Bat Cigarettenfab Gmbh Ultraleicht-Koaxialcigarette mit mehrteiligem Filter
AR013493A1 (es) 1997-09-15 2000-12-27 Procter & Gamble COMPUESTO DE QUINOLONA, SU USO PARA LA FABRICACIoN DE UN MEDICAMENTO Y COMPOSICIoN FARMACEUTICA QUE LO COMPRENDE
DE19751948A1 (de) 1997-11-24 1999-05-27 Bayer Ag Verfahren zur Herstellung von 8-Methoxy-Chinoloncarbonsäuren
CN1258531C (zh) * 1999-03-10 2006-06-07 第一制药株式会社 芳香族取代基取代的氨基甲基吡咯烷衍生物
US6667406B1 (en) * 1999-03-10 2003-12-23 Ortho-Mcneil Pharmaceutical, Inc. Methods for the synthesis of complex reduced isoindole, isooxyindole and isooxyquinoline libraries
AU2002230891B2 (en) 2000-12-14 2005-04-07 The Procter & Gamble Company Antimicrobial quinolones
HUP0303457A3 (en) 2000-12-14 2008-05-28 Procter & Gamble Antimicrobial 2-pyridones, compositions containing them and their use
WO2007110835A2 (en) * 2006-03-28 2007-10-04 The Procter & Gamble Company A coupling process for preparing quinolone intermediates
HRP20110558T1 (hr) * 2006-03-28 2011-09-30 Warner Chilcott Company Malatne soli i polimorfi od (3s, 5s)-7-[3-amino-5-metil-piperidinil]-1-ciklopropil-1, 4-dihidro-8-metoksi-4-okso-3-kinolinkarboksilne kiseline
JP4876165B2 (ja) * 2006-03-28 2012-02-15 ザ プロクター アンド ギャンブル カンパニー キノロン中間体を調製するための水素化物還元法
RU2769675C2 (ru) * 2020-07-21 2022-04-04 Сергей Иванович Орлов Устройство передачи информации через барьер гальванической развязки

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0343560A2 (en) * 1988-05-23 1989-11-29 Wakunaga Seiyaku Kabushiki Kaisha Isoindoline derivative
EP0343524A1 (en) * 1988-05-23 1989-11-29 Shionogi Seiyaku Kabushiki Kaisha Pyridonecarboxylic acids and antibacterial agents
WO1992012146A1 (en) * 1990-12-27 1992-07-23 Banyu Pharmaceutical Co., Ltd. Pyridonecarboxylic acid derivative

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2030217A1 (en) * 1989-11-21 1991-05-22 Jun Imose Pyridone-carboxylic acid derivatives useful as veterinary medicines
DE4120646A1 (de) * 1991-06-22 1992-12-24 Bayer Ag 7-isoindolinyl-chinolon- und naphthyridoncarbonsaeure-derivate
DE4123918A1 (de) * 1991-07-19 1993-01-21 Bayer Ag 8-vinyl- und 8-ethinyl-chinoloncarbonsaeuren
US5468742A (en) * 1991-07-19 1995-11-21 Bayer Aktiengesellschaft 8-vinyl- and 9-ethinyl-quinolone-carboxylic acids
DE4301246A1 (de) * 1993-01-19 1994-07-21 Bayer Ag Chinolon- und Naphthyridoncarbonsäurederivate
DE4408212A1 (de) * 1994-03-11 1995-09-14 Bayer Ag 5-Vinyl- und 5-Ethinyl-chinolon- und -naphthyridon-carbonsäuren

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0343560A2 (en) * 1988-05-23 1989-11-29 Wakunaga Seiyaku Kabushiki Kaisha Isoindoline derivative
EP0343524A1 (en) * 1988-05-23 1989-11-29 Shionogi Seiyaku Kabushiki Kaisha Pyridonecarboxylic acids and antibacterial agents
WO1992012146A1 (en) * 1990-12-27 1992-07-23 Banyu Pharmaceutical Co., Ltd. Pyridonecarboxylic acid derivative

Also Published As

Publication number Publication date
US5556979A (en) 1996-09-17
US5739339A (en) 1998-04-14
KR100288522B1 (ko) 2001-05-02
ID23959A (id) 1994-03-10
NO933132D0 (no) 1993-09-02
MX9305256A (es) 1995-01-31
NZ280374A (en) 1996-08-27
HU9302593D0 (en) 1993-11-29
EP0588166A3 (enExample) 1994-04-27
AU4492793A (en) 1994-03-24
ES2088618T3 (es) 1996-08-16
HU222348B1 (hu) 2003-06-28
FI934004L (fi) 1994-03-16
AU6205996A (en) 1996-10-24
FI934004A0 (fi) 1993-09-13
CZ190393A3 (en) 1994-04-13
RU2111964C1 (ru) 1998-05-27
PL177238B1 (pl) 1999-10-29
ZA936759B (en) 1994-04-11
CA2469296A1 (en) 1994-03-16
HUT65216A (en) 1994-05-02
UA35562C2 (uk) 2001-04-16
ATE138920T1 (de) 1996-06-15
DE59302809D1 (de) 1996-07-11
DK0588166T3 (da) 1996-10-07
GR3020484T3 (en) 1996-10-31
SK99093A3 (en) 1994-04-06
PL177155B1 (pl) 1999-09-30
CA2105923A1 (en) 1994-03-16
AU682134B2 (en) 1997-09-18
DE4230804A1 (de) 1994-03-17
KR940007027A (ko) 1994-04-26
NO933132L (no) 1994-03-16
CN1087634A (zh) 1994-06-08
FI934004A7 (fi) 1994-03-16
AU668743B2 (en) 1996-05-16
PL300385A1 (en) 1994-03-21
JPH06263755A (ja) 1994-09-20
MY131373A (en) 2007-08-30
PL177140B1 (pl) 1999-09-30
IL106990A0 (en) 1993-12-28
NO304944B1 (no) 1999-03-08
CZ288493B6 (en) 2001-06-13
IL106990A (en) 1997-02-18
CA2105923C (en) 2004-12-28
TW316899B (enExample) 1997-10-01
NZ248631A (en) 1996-01-26
EP0588166B1 (de) 1996-06-05
SK282274B6 (sk) 2002-01-07
JP3199930B2 (ja) 2001-08-20
US6018054A (en) 2000-01-25
EP0588166A2 (de) 1994-03-23

Similar Documents

Publication Publication Date Title
CN1044118C (zh) 7－异二氢氮杂茚基－喹诺酮衍生物及其制备方法
CN1036193C (zh) 7-未取代的或取代的氨基-5-氮杂螺(2，4)庚烷的制法
CN1027165C (zh) 7-环取代-3-喹诺酮羧酸衍生物的制备方法
CN1074218A (zh) 喹诺酮甲酸和萘啶酮甲酸衍生物
CN1105715C (zh) 新型吡啶酮羧酸衍生物或其盐以及以它们为有效成分的抗菌剂
CN1090285A (zh) 喹诺酮羧酸类
CN1033751C (zh) 用于治疗的抗菌的光学活性吡啶酮羧酸衍生物的制备方法
CN1070191C (zh) 新的喹诺酮－或萘酮－羧酸衍生物或其盐
CN1025192C (zh) 氮杂双环喹诺酮羧酸的制备方法
CN1068115A (zh) 7-异二氢吲哚基-喹诺酮和-1，4二氢-1，8二氮杂萘-4-酮羧酸衍生物
CN100335054C (zh) 喹诺酮羧酸和萘啶酮羧酸衍生物在治疗幽门螺杆菌感染和其相关的胃十二指肠疾病中的应用
CN1068114A (zh) 7-氮杂异二氢吲哚基-喹诺酮和二氮杂萘酮羧酸衍生物
CN87106925A (zh) 1-叔烷基取代的二氮杂萘和喹啉羧酸抗菌剂
CN1620290A (zh) 作为5－羟色胺－6配体的吲哚基烷基胺衍生物
CN1849316A (zh) 7－(4－取代－3－环丙基氨基甲基－1－吡咯烷基)喹诺酮羧酸衍生物
CN1048242C (zh) 5-氨基-8-甲基-7-吡咯烷喹啉-3-羧酸衍生物及其制造方法和中间体化合物
CN1103769C (zh) 三环胺衍生物
CN87100354A (zh) 7-(氮杂双环烷基)-喹诺酮羧酸和7-(氮杂双环烷基)-二氮杂萘酮羧酸的衍生物
CN1111629A (zh) 5-乙烯基-、5-乙炔基喹诺酮羧酸类和5-乙烯基-、5-乙炔基萘啶酮羧酸类
CN1041202C (zh) 一种具有药物活性的喹诺酮羧酸衍生物
CN1114607C (zh) 喹诺酮羧酸衍生物
CN1063747C (zh) 喹诺酮－及二氮杂萘酮羧酸衍生物
CN1028102C (zh) 螺环化合物的制备
CN1184221C (zh) 有7－(7－氨甲基－5－氮杂螺[2,4]庚烷)取代基的新喹啉羧酸衍生物及其制备方法
CN1041731C (zh) 吡啶并[1,2,3—d,e][1,3,4]苯并噁二嗪衍生物

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee